Saffron has shown positive results in treating a wide range of health issues, including depression, cancer, and inflammation. Scientific studies have also shown saffron to be an effective treatment against macular degeneration.
Many cultures use saffron for its health benefits, preparing in a tea or mixing with milk to help ingestion. Whilst we don't sell saffron tablets at Saffrondust, for those interested in taking a prepared saffron extract in a measured dosage we recommend MDRevision, a New Zealand based manufacturer specialising in saffron extract made from quality Novin brand saffron.
Our sincere thanks to Geoffrey Leigh, Clinical Director of the Australian Institute for Biological Medicine for assisting us in our research for this article. Geoffrey and his team are researching the use of saffron and other natural medicines as nutritional supplements in the treatment of cancer. This cutting edge research is world leading and is being done right here in Australia.
Appetite Suppression :
This is the Dr Oz saffron show that the US is talking about, and which spawned an industry in satiereal saffron extracts. You don't need to take saffron in a pill, you can use saffron in your food or drink saffron tea to extract the health benefits. Remember to either powder your saffron to release the active ingredients, or steep it in warm water for at least 20 minutes to make a tea - releasing the active chemicals into the water.
The show mentions 88mg per day as the recommended dosage for appetite suppression, which equals about a pinch and a half of saffron. We would recommend a lesser dosage of high quality Persian saffron. You can use 8-10 threads brewed into warm water which is ample saffron to realise the health benefits of saffron tea. 1g of saffron will make around 50 cups of saffron tea, and at a cup a day our 10g vial will last you well over a year.
A link to the actual study published in the Journal of Nutrition research is provided here
Colorectal cancer is the 2nd leading cause of cancer related death in the US. Crocin extracted from Crocus Sativus (saffron) has been shown in clinical studies to inhibit the growth of colorectal cancer cells (Aung et al, 2007)
Crocin, safranel, and picrocrocin, active compounds found in saffron have been shown to inhibit the growth of human cancer cells. Crocin in particular because of its high solubility in water shows significant promise as a cancer therapeutic agent (Escribano et al, 1996)
Recent scientific findings have shown saffron to be one of the most promising cancer chemopreventative agents currently being studied (Abdullaev, 2002)
Depression is the world's 4th largest cause of disability after respiratory infections, prenatel conditions, and HIV/AIDs. 30mg of saffron per day has been found to be an effective treatment against mild to moderate depression (Akhondzadeh et al, 2004; Noorbala et al, 2005)
Saffron stigmas and petals have both been shown to be an effective treatment for clinical depression - it is proposed that the crocin and safranel compounds act as seratonin reuptake inhibitors (Morgan & Jorm, 2008)
The video below gives a brief overview of saffron as a treatment for depression :
Cardiovascular Disease :
Antioxidants such as lycopene and crocetin ingested through drinking of saffron tea, have been found to show positive results in the treatment of heart disease by strengthening the circulatory system (Kamalipour and Akhondzadeh, 2011).
The video below highlights the benefits of saffron as a PMS treatment :
Crocin, an active compound found in saffron, has been shown to improve learning and reduce memory loss, and could be an effective treatment for neurological disorders and long term memory loss (Abe & Saito, 2000)
Clinical trials have shown that 30mg of saffron taken daily is a safe and effective treatment against mild to moderate Alzheimers Disease (Akhonzadeh et al, 2010)
Opium Withdrawal Symptoms :
Crocin and safranel, active compounds found in saffron, have been shown to interact with the opoid system, and reduce the effect of withdrawal symptoms from morphine addiction (Hosseinzadeh & Jahanian, 2010)